Your session is about to expire
← Back to Search
Caffeine Reduction Manual for Caffeine Withdrawal
N/A
Waitlist Available
Led By Mary M Sweeney, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, at the time of intervention visit (within 1-2 weeks of screening), at 7 weeks post-intervention visit, at 14 weeks post-intervention visit
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a step-by-step plan to help people slowly cut down on caffeine. It targets those who struggle to reduce caffeine despite health issues like anxiety and sleep problems. Participants follow the plan online, reporting their progress and any health improvements.
Eligible Conditions
- Caffeine Withdrawal
- Anxiety Disorders
- Insomnia
- Traveler's Diarrhea
- Functional Heartburn
- Sleep Disorders
- Caffeine
- Gastrointestinal Dysfunction
- Generalized Anxiety Disorder
- Heartburn
- Diarrhea
- Caffeine Addiction
- Anxiety
- Caffeine-induced anxiety
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, at 7 weeks post-intervention visit, at 14 weeks post-intervention visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, at 7 weeks post-intervention visit, at 14 weeks post-intervention visit
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Treatment acceptability as assessed by treatment acceptability questionnaire
Treatment adherence as assessed by percentage of completed assessments
Secondary study objectives
Anxiety
Change in anxiety as assessed by the PROMIS-Anxiety-8a
Change in caffeine consumption (in milligrams)
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Caffeine Reduction Manual, Immediate Treatment GroupExperimental Treatment1 Intervention
Weekly caffeine consumption is to be measured before and after using the caffeine reduction program, which has been summarized in a "Guide to Caffeine Reduction and Cessation" manual to help people reduce their caffeine use. Those in the immediate treatment group will receive the guide immediately after screening.
Group II: Caffeine Reduction Manual, Delayed Treatment GroupExperimental Treatment1 Intervention
Weekly caffeine consumption is to be measured before and after using the caffeine reduction program, which has been summarized in a "Guide to Caffeine Reduction and Cessation" manual to help people reduce their caffeine use. Those in the delayed treatment group will receive the guide seven weeks after screening.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Caffeine Reduction Manual
2020
N/A
~110
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,586 Previous Clinical Trials
3,328,421 Total Patients Enrolled
Johns Hopkins UniversityLead Sponsor
2,326 Previous Clinical Trials
14,874,620 Total Patients Enrolled
Mary M Sweeney, PhDPrincipal InvestigatorJohns Hopkins University
1 Previous Clinical Trials
1 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You want to participate in a study that will help you reduce or stop your caffeine intake.You must be able to speak, read, and write in English with ease.There are no restrictions on caffeine intake.You have access to a smartphone, tablet, or other computer with a video camera.You live in the United States.You need to have a good reason for reducing your caffeine intake.
Research Study Groups:
This trial has the following groups:- Group 1: Caffeine Reduction Manual, Delayed Treatment Group
- Group 2: Caffeine Reduction Manual, Immediate Treatment Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Caffeine Withdrawal Patient Testimony for trial: Trial Name: NCT04560595 — N/A
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger